OCUL: Ocular Therapeutix, Inc.
Performance
OCUL -36.87%
Watchlist
Select an item
Summary
OCUL at a glance
OCUL returned -36.87% over the past year and -0.35% a year over five years. Its worst drop in that year was -60.96%, smaller than 12% of stocks on Redstone, and its Sharpe ratio of -0.28 beats 16% of stocks on Redstone. It pays no dividends.
Current Drawdown
-57.48%
Rolling Volatility
73.65%
Actions
Metrics
Risk Indicators
Alpha-34.82%
Beta1.36x
Sharpe-0.28
Sortino-0.42
Omega0.95
Calmar-0.60
Martin-0.52
Profile
About OCUL
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.5B
- Listed
- Jul 2014
- Employees
- 325
- Headquarters
- Bedford, MA
- Website
- ocutx.com
Comparisons